Mercredi, H.C. Wainwright a maintenu sa notation Neutre sur Geron Corporation (NASDAQ: GERN) suite à l’approbation récente de son médicament Rytelo par la Commission européenne. Selon les données d’ I ...
Si le BC Verviers est premier de la R2, cela s’est agité en coulisses ces derniers jours. Le capitaine Julien Vermierdt ne ...
9d
Des membres clés de la magistrature fédérale américaine ont mis en garde mardi contre un nombre croissant de menaces visant leurs collègues et ont qualifié de préoccupants les appels à ...
Malgré cela, Geron a déclaré une position de trésorerie solide de 502,9 millions $ à la fin de l’année. Les analystes de H.C. Wainwright ont dégradé la note de l’action Geron de Achat à Neutre, citant ...
Geron (NASDAQ:GERN – Get Free Report)‘s stock had its “neutral” rating reiterated by equities research analysts at HC Wainwright in a note issued to investors on Wednesday,Benzinga reports.
John Scarlett; Chairman of the Board, President, Chief Executive Officer; Geron Corp Jim Ziegler; Executive Vice President, Chief Commercial Officer; Geron Corp Joseph Eid; Executive Vice ...
Geron stock opened at $1.64 on Wednesday. Geron has a 1-year low of $1.46 and a 1-year high of $5.34. The firm has a market capitalization of $1.04 billion, a price-to-earnings ratio of -5.13 and ...
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that John “Chip” A. Scarlett, M.D ...
Geron stock is seeing a dramatic pullback following the company's fourth-quarter report. Geron's earnings in Q4 fell short of Wall Street's expectations, and management had worrying guidance for ...
FOSTER CITY, Calif., March 11, 2025--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback